A Definitive Role of RhoC in Metastasis of Orthotopic Lung Cancer in Mice

Clinical Cancer Research

Volumn 10, Issue 3, 2004, Pages 1192-1200

  Ikoma, Tetsuro ^a,b   Takahashi, Tomoyuki ^b   Nagano, Satoshi ^b,c   Li, Yun Mo ^a   Ohno, Yasushi ^a   Ando, Kazuki ^b   Fujiwara, Takako ^e   Fujiwara, Hisayoshi ^a   Kosai, Ken Ichiro ^b,c,d  

^a GIFU UNIVERSITY   (Japan)

^b GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KURUME UNIVERSITY   (Japan)

^d KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e KYOTO WOMEN'S UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GUANINE NUCLEOTIDE BINDING PROTEIN; MATRIX METALLOPROTEINASE; PROTEIN DNRHO; PROTEIN RHOC; RAS PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CELL MIGRATION; CELL MOTILITY; CHEMOTAXIS; CONTROLLED STUDY; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENETIC TRANSDUCTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; ISOGRAFT; LUNG CANCER; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; UPREGULATION; ZYMOGRAPHY;

ANIMALS; CARCINOMA, LEWIS LUNG; CELL DIVISION; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; GELATIN; GENES, DOMINANT; GREEN FLUORESCENT PROTEINS; IMMUNOHISTOCHEMISTRY; LUMINESCENT PROTEINS; LUNG NEOPLASMS; LYMPH NODES; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PROGNOSIS; RAS PROTEINS; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHO GTP-BINDING PROTEINS; RNA, MESSENGER; TIME FACTORS; UP-REGULATION;

EID: 1042278714     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-03-0275     Document Type: Article

References (42)

1. Beadsmoore, C. J., and Screaton, N. J. Classification, staging and prognosis of lung cancer. Eur. J. Radiol., 45: 8-17, 2003.
2. Colice, G. L., Rubins, J., and Unger, M. Follow-up and surveillance of the lung cancer patient following curative-intent therapy. Chest, 123: 272S-283S, 2003.
3. Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., and Thun, M. J. Cancer Statistics, 2003. CA Cancer J. Clin., 53: 5-26, 2003.
4. Rosell, R., Gomez-Codina, J., Camps, C., Javier Sanchez, J., Maestre, J., Padilla, J., Canto, A., Abad, A., and Roig, J. Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial. Lung Cancer, 26: 7-14, 1999.
5. Lassen, U., Osterlind, K., Hansen, M., Dombernowsky, P., Bergman, B., and Hansen, H. H. Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years - an analysis of 1,714 consecutive patients. J. Clin. Oncol., 13: 1215-1220, 1995.
6. Fukunaga, M., Takamori, S., Hayashi, A., Shirouzu, K., and Kosai, K. Adenoviral herpes simplex virus thymidine kinase gene therapy in an orthotopic lung cancer model. Ann. Thorac. Surg., 73: 1740-1746, 2002.
7. Kwong, Y. L., Chen, S. H., Kosai, K., Finegold, M., and Woo, S. L. Combination therapy with suicide and cytokine genes for hepatic metastases of lung cancer. Chest, 112: 1332-1337, 1997.
8. Liotta, L. A., Steeg, P. S., and Stetler-Stevenson, W. G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64: 327-336, 1991.
9. Clark, E. A., Golub, T. R., Lander, E. S., and Hynes, R. O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature (Lond.), 406: 532-535, 2000.
10. Etienne-Manneville, S., and Hall, A. Rho GTPases in cell biology. Nature (Lond.), 420: 629-635, 2002.
11. Tapon, N., and Hall, A. Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr. Opin. Cell Biol., 9: 86-92, 1997.
12. Sahai, E., and Marshall, C. J. RHO-GTPases and cancer. Nat. Rev. Cancer, 2: 133-142, 2002.
13. van Golen, K. L., Bao, L., DiVito, M. M., Wu, Z., Prendergast, G. C., and Merajver, S. D. Reversion of RhoC GTPase-induced inflammatory breast cancer phenotype by treatment with a farnesyl transferase inhibitor. Mol. Cancer Ther., 1: 575-583, 2002.
14. Kleer, C. G., van Golen, K. L., Zhang, Y., Wu, Z. F., Rubin, M. A., and Merajver, S. D. Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. Am. J. Pathol., 160: 579-584, 2002.
15. Horiuchi, A., Imai, T., Wang, C., Ohira, S., Feng, Y., Nikaido, T., and Konishi, I. Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma. Lab. Investig., 83: 861-870, 2003.
16. Suwa, H., Ohshio, G., Imamura, T., Watanabe, G., Arii, S., Imamura, M., Narumiya, S., Hiai, H., and Fukumoto, M. Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. Br. J. Cancer, 77: 147-152, 1998.
17. Itoh, T., Tanioka, M., Matsuda, H., Nishimoto, H., Yoshioka, T., Suzuki, R., and Uehira, M. Experimental metastasis is suppressed in MMP-9-deficient mice. Clin. Exp. Metastasis, 17: 177-181, 1999.
18. Ailenberg, M., and Silverman, M. Cellular activation of mesangial gelatinase A by cytochalasin D is accompanied by enhanced mRNA expression of both gelatinase A and its membrane-associated gelatinase A activator (MT-MMP). Biochem. J., 313: 879-884, 1996.
19. Qiu, R. G., Chen, J., McCormick, F., and Symons, M. A role for Rho in Ras transformation. Proc. Natl. Acad. Sci. USA, 92: 11781-11785, 1995.
20. Qiu, R. G., Chen, J., Kirn, D., McCormick, F., and Symons, M. An essential role for Rac in Ras transformation. Nature (Lond.), 374: 457-459, 1995.
21. Kosai, K. I., Finegold, M. J., Thi-Huynh, B. T., Tewson, M., Ou, C. N., Bowles, N., Woo, S. L., Schwall, R. H., and Darlington, G. J. Retrovirus-mediated in vivo gene transfer in the replicating liver using recombinant hepatocyte growth factor without liver injury or partial hepatectomy. Hum. Gene Ther., 9: 1293-1301, 1998.
22. Doki, Y., Murakami, K., Yamaura, T., Sugiyama, S., Misaki, T., and Saiki, I. Mediastinal lymph node metastasis model by orthotopic intrapulmonary implantation of Lewis lung carcinoma cells in mice. Br. J. Cancer, 79: 1121-1126, 1999.
23. Liu, X., Sun, Y., Constantinescu, S. N., Karam, E., Weinberg, R. A., and Lodish, H. F. Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc. Natl. Acad. Sci. USA, 94: 10669-10674, 1997.
24. Takai, Y., Sasaki, T., and Matozaki, T. Small GTP-binding proteins. Physiol. Rev., 81: 153-208, 2001.
25. Yeramian, P., Chardin, P., Madaule, P., and Tavitian, A. Nucleotide sequence of human rho cDNA clone 12. Nucleic Acids Res., 15: 1869, 1987.
26. Chardin, P., Madaule, P., and Tavitian, A. Coding sequence of human rho cDNAs clone 6 and clone 9. Nucleic Acids Res., 16: 2717, 1988.
27. Abraham, M. T., Kuriakose, M. A., Sacks, P. G., Yee, H., Chiriboga, L., Bearer, E. L., and Delacure, M. D. Motility-related proteins as markers for head and neck squamous cell cancer. Laryngoscope, 111: 1285-1289, 2001.
28. Kamai, T., Kawakami, S., Koga, F., Arai, G., Takagi, K., Arai, K., Tsujii, T., and Yoshida, K. I. RhoA is associated with invasion and lymph node metastasis in upper urinary tract cancer. BJU Int., 91: 234-238, 2003.
29. Fritz, G., Just, I., and Kaina, B. Rho GTPases are over-expressed in human tumors. Int. J. Cancer, 81: 682-687, 1999.
30. van Golen, K. L., Bao, L. W., Pan, Q., Miller, F. R., Wu, Z. F., and Merajver, S. D. Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer. Clin. Exp. Metastasis, 19: 301-311, 2002.
31. Kamai, T., Tsujii, T., Arai, K., Takagi, K., Asami, H., Ito, Y., and Oshima, H. Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin. Cancer Res., 9: 2632-2641, 2003.
32. Fritz, G., Bráchetti, C., Bahlmann, F., Schmidt, M., and Kaina, B. Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters. Br. J. Cancer, 87: 635-644, 2002.
33. Tokman, M. G., Porter, R. A., and Williams, C. L. Regulation of cadherin-mediated adhesion by the small GTP-binding protein Rho in small cell lung carcinoma cells. Cancer Res., 57: 1785-1793, 1997.
34. Khosravi-Far, R., Solski, P., Clark, G., Kinch, M., and Der, C. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation. Mol. Cell. Biol., 15: 6443-6453, 1995.
35. Seiki, M. Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett., 194: 1-11, 2003.
36. Lim, M., and Jablons, D. M. Matrix metalloproteinase expression in lung cancer. Methods Mol. Med., 74: 349-356, 2003.
37. Tokuraku, M., Sato, H., Murakami, S., Okada, Y., Watanabe, Y., and Seiki, M. Activation of the precursor of gelatinase A/72 kDa type IV collagenase/ MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int. J. Cancer, 64: 355-359, 1995.
38. Zhuge, Y., and Xu, J. Rac1 mediates type I collagen-dependent MMP-2 activation: role in cell invasion across collagen barrier. J. Biol. Chem., 276: 16248-16256, 2001.
39. Engers, R., Springer, E., Michiels, F., Collard, J. G., and Gabbert, H. E. Rac affects invasion of human renal cell carcinomas by upregulating tissue inhibitor of metalloproteinases (TIMP)-1 and TIMP-2 expression. J. Biol. Chem., 276: 41889-41897, 2001.
40. Matsumoto, Y., Tanaka, K., Harimaya, K., Nakatani, F., Matsuda, S., and Iwamoto, Y. Small GTP-binding protein, Rho, both increased and decreased cellular motility, activation of matrix metalloproteinase 2 and invasion of human osteosarcoma cells. Jpn. J. Cancer Res., 92: 429-438, 2001.
41. Itoh, Y., Takamura, A., Ito, N., Maru, Y., Sato, H., Suenaga, N., Aoki, T., and Seiki, M. Homophilic complex formation of MTI-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J., 20: 4782-4793, 2001.
42. Mori, H., Tomari, T., Koshikawa, N., Kajita, M., Itoh, Y., Sato, H., Tojo, H., Yana, I., and Seiki, M. CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain. EMBO J., 21: 3949-3959, 2002.